|
A Randomized, Controlled, Parallel-Group, Trial on the Long-term Effects of Melatonin on Fatigue Associated With Breast Cancer and Its Adjuvant Treatments
|
12 December 2025 |
|
Therapeutic Potential of Melatonin in Gastrointestinal Cancers: Molecular Mechanisms, Preclinical Evidence and Clinical Implications
|
11 December 2025 |
|
Vitamins A and D and Their Combinations for Breast and Colorectal Cancers: Analysis of the Clinical, Epidemiological, Preclinical and Transcriptomic Data
|
03 December 2025 |
|
Dually Decorated Palmitate-Containing Lipid Nanoparticles for the Targeted Delivery of siRNAs against HER2 and Hsp27 in HER2+ Breast Cancer
|
28 November 2025 |
|
Melatonin promotes cytotoxicity while reducing cell motility and antioxidant defenses in ovarian cancer cell lines
|
28 November 2025 |
|
Identifying potential mechanisms of circadian rhythm-related gene marker prognosis, immune infiltration, and melatonin intervention in thyroid cancer based on bioinformatics and network pharmacology
|
28 November 2025 |
|
Evaluating the Cardioprotective Effects of Melatonin in Non-metastatic Breast Cancer Patients Receiving Doxorubicin Plus Cyclophosphamide: A Triple-Blind, Placebo-Controlled Randomized Controlled Trial
|
14 November 2025 |
|
Natural Compound Melatonin Suppresses Breast Cancer Development by Regulating Circadian Rhythm
|
14 November 2025 |
|
Melatonin Overcomes Cancer Multidrug Resistance by Downregulating ABCB1 Expression and Modulating Mitochondrial Function
|
07 November 2025 |
|
Modulating effects of famotidine and melatonin on high dose radiation induced cell lethality in normal human and cancer cell lines
|
24 October 2025 |
News-Papers
Testimonial
Video Gallery 
